NCT03914625 2026-03-18A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 3 Active not recruiting6,720 enrolled